Response to 'Quantitative Clinical Pharmacology INPUT to SARS‐CoV‐2 Therapeutics Should be Based on Robust Data'

Autor:	Radojka M. Savic, Emma Hughes, Erika Wallender, Jacqueline P Ernest, Maria Garcia-Cremades, Belén P. Solans
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 030226 pharmacology & pharmacy law.invention 03 medical and health sciences Clinical Betacoronavirus 0302 clinical medicine law Pandemic medicine Humans Pharmacology (medical) Viral Pharmacology & Pharmacy Pandemics Pharmacology Clinical pharmacology biology business.industry SARS-CoV-2 COVID-19 Pneumonia Pharmacology and Pharmaceutical Sciences biology.organism_classification medicine.disease SARS Virus Virology Good Health and Well Being 030220 oncology & carcinogenesis business Coronavirus Infections
Zdroj:	Clinical Pharmacology & Therapeutics Clinical pharmacology and therapeutics, vol 108, iss 2
ISSN:	1532-6535 0009-9236
DOI:	10.1002/cpt.1873
Popis:	Author(s): Garcia-Cremades, Maria; Solans, Belen P; Hughes, Emma; Ernest, Jacqueline P; Wallender, Erika; Savic, Radojka M
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e202e66507d9119f646be57e1a118bb7 Zobrazit plný text záznamu Plný text